Shintaro Ogawa

1.2k total citations
26 papers, 873 citations indexed

About

Shintaro Ogawa is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Shintaro Ogawa has authored 26 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biological Psychiatry, 8 papers in Psychiatry and Mental health and 7 papers in Pharmacology. Recurrent topics in Shintaro Ogawa's work include Tryptophan and brain disorders (13 papers), Stress Responses and Cortisol (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Shintaro Ogawa is often cited by papers focused on Tryptophan and brain disorders (13 papers), Stress Responses and Cortisol (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Shintaro Ogawa collaborates with scholars based in Japan, Canada and United States. Shintaro Ogawa's co-authors include Hiroshi Kunugi, Hiroaki Hori, Kotaro Hattori, Miho Ota, Toshiya Teraishi, Ikki Ishida, Teruhiko Higuchi, Shinsuke Hidese, Takamasa Noda and Shoko Tsuchimine and has published in prestigious journals such as PLoS ONE, Scientific Reports and Human Molecular Genetics.

In The Last Decade

Shintaro Ogawa

24 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shintaro Ogawa Japan 16 362 202 188 145 133 26 873
Paulina Misztak Poland 20 427 1.2× 232 1.1× 197 1.0× 119 0.8× 290 2.2× 49 1.1k
Camila O. Arent Brazil 17 297 0.8× 257 1.3× 125 0.7× 118 0.8× 237 1.8× 34 844
Ann Gardner Sweden 13 380 1.0× 268 1.3× 228 1.2× 179 1.2× 143 1.1× 22 891
Aslı Sarandöl Türkiye 14 404 1.1× 157 0.8× 279 1.5× 144 1.0× 210 1.6× 52 989
Romain Colle France 19 336 0.9× 240 1.2× 180 1.0× 156 1.1× 168 1.3× 84 1.2k
Lucija Tudor Croatia 16 193 0.5× 186 0.9× 110 0.6× 136 0.9× 96 0.7× 43 669
Adriano José Maia Chaves Filho Brazil 18 504 1.4× 330 1.6× 250 1.3× 186 1.3× 174 1.3× 52 1.1k
Selçuk Kırlı Türkiye 14 493 1.4× 152 0.8× 347 1.8× 138 1.0× 242 1.8× 40 1.1k
Sebastiano Alfio Torrisi Italy 19 202 0.6× 265 1.3× 168 0.9× 205 1.4× 69 0.5× 32 863
Laura Mahan United States 12 348 1.0× 229 1.1× 241 1.3× 282 1.9× 73 0.5× 14 958

Countries citing papers authored by Shintaro Ogawa

Since Specialization
Citations

This map shows the geographic impact of Shintaro Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shintaro Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shintaro Ogawa more than expected).

Fields of papers citing papers by Shintaro Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shintaro Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shintaro Ogawa. The network helps show where Shintaro Ogawa may publish in the future.

Co-authorship network of co-authors of Shintaro Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shintaro Ogawa. A scholar is included among the top collaborators of Shintaro Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shintaro Ogawa. Shintaro Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogawa, Shintaro, Hiroaki Hori, Mariko Itoh, et al.. (2025). Serum lipid and plasma fatty acid profiles in PTSD patients and healthy individuals: Associations with symptoms, cognitive function, and inflammatory markers. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 138. 111298–111298.
2.
3.
Hattori, Kotaro, Takamasa Noda, Miho Ota, et al.. (2024). Possible association of elevated CSF IL‐6 levels with anxiety and frustration in psychiatric disorders. Psychiatry and Clinical Neurosciences. 78(12). 792–799. 1 indexed citations
4.
Matsuno, Hitomi, Shoko Tsuchimine, Kazunori Ohashi, et al.. (2022). Association between vascular endothelial growth factor-mediated blood–brain barrier dysfunction and stress-induced depression. Molecular Psychiatry. 27(9). 3822–3832. 102 indexed citations
5.
Ogawa, Shintaro, Shoko Tsuchimine, & Hiroshi Kunugi. (2018). Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence. Journal of Psychiatric Research. 105. 137–146. 39 indexed citations
6.
Ota, Miho, et al.. (2018). A Single Intraperitoneal Injection of Endotoxin Changes Glial Cells in Rats as Revealed by Positron Emission Tomography Using [11C]PK11195. Nuclear Medicine and Molecular Imaging. 52(3). 224–228. 1 indexed citations
7.
Hattori, Kotaro, Shintaro Ogawa, Daimei Sasayama, et al.. (2017). Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder. The Journal of Clinical Psychiatry. 78(8). e947–e956. 22 indexed citations
8.
Ogawa, Shintaro, Norie Koga, Kotaro Hattori, et al.. (2017). Plasma amino acid profile in major depressive disorder: Analyses in two independent case-control sample sets. Journal of Psychiatric Research. 96. 23–32. 56 indexed citations
9.
Adachi, Naoki, Aya Yoshimura, Shuichi Chiba, Shintaro Ogawa, & Hiroshi Kunugi. (2017). Rotigotine, a dopamine receptor agonist, increased BDNF protein levels in the rat cortex and hippocampus. Neuroscience Letters. 662. 44–50. 19 indexed citations
10.
Yui, Kunio, Yohei Kawasaki, Hiroshi Yamada, & Shintaro Ogawa. (2016). Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders. CNS & Neurological Disorders - Drug Targets. 15(5). 587–596. 64 indexed citations
11.
Sasayama, Daimei, Kotaro Hattori, Shintaro Ogawa, et al.. (2016). Genome-wide quantitative trait loci mapping of the human cerebrospinal fluid proteome. Human Molecular Genetics. 26(1). ddw366–ddw366. 25 indexed citations
12.
Teraishi, Toshiya, Hiroaki Hori, Daimei Sasayama, et al.. (2015). 13C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder. Scientific Reports. 5(1). 15994–15994. 15 indexed citations
13.
Kunugi, Hiroshi, Hiroaki Hori, & Shintaro Ogawa. (2015). Biochemical markers subtyping major depressive disorder. Psychiatry and Clinical Neurosciences. 69(10). 597–608. 82 indexed citations
14.
Ogawa, Shintaro, Kotaro Hattori, Daimei Sasayama, et al.. (2015). Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder. Scientific Reports. 5(1). 7796–7796. 37 indexed citations
15.
16.
Ota, Miho, Shintaro Ogawa, Koichi Kato, Chisato Wakabayashi, & Hiroshi Kunugi. (2015). Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: A positron emission tomography using [18F]fallypride. Psychiatry Research Neuroimaging. 232(1). 92–97. 3 indexed citations
17.
Ogawa, Shintaro & Hiroshi Kunugi. (2015). Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants. Current Neuropharmacology. 13(6). 760–775. 44 indexed citations
18.
Ogawa, Shintaro, Takashi Fujii, Norie Koga, et al.. (2014). PlasmaL-Tryptophan Concentration in Major Depressive Disorder. The Journal of Clinical Psychiatry. 75(9). e906–e915. 138 indexed citations
19.
Teraishi, Toshiya, Hiroaki Hori, Daimei Sasayama, et al.. (2014). Relationship between Lifetime Suicide Attempts and Schizotypal Traits in Patients with Schizophrenia. PLoS ONE. 9(9). e107739–e107739. 22 indexed citations
20.
Ogawa, Shintaro & Hiroshi Ichinose. (2006). Effect of metals and phenylalanine on the activity of human tryptophan hydroxylase-2: Comparison with that on tyrosine hydroxylase activity. Neuroscience Letters. 401(3). 261–265. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paulina Misztak Breakdown of academic impact, for papers by Camila O. Arent Breakdown of academic impact, for papers by Ann Gardner Breakdown of academic impact, for papers by Aslı Sarandöl Breakdown of academic impact, for papers by Romain Colle Breakdown of academic impact, for papers by Lucija Tudor Breakdown of academic impact, for papers by Adriano José Maia Chaves Filho Breakdown of academic impact, for papers by Selçuk Kırlı Breakdown of academic impact, for papers by Sebastiano Alfio Torrisi Breakdown of academic impact, for papers by Laura Mahan
Rankless by CCL
2026